Article | Published:

Kinase suppressor of Ras-1 protects against pulmonary Pseudomonas aeruginosa infections

Nature Medicine volume 17, pages 341346 (2011) | Download Citation

Abstract

Pseudomonas aeruginosa is a Gram-negative pathogen that causes severe infections in immunocompromised individuals and individuals with cystic fibrosis or chronic obstructive pulmonary disease (COPD). Here we show that kinase suppressor of Ras-1 (Ksr1)-deficient mice are highly susceptible to pulmonary P. aeruginosa infection accompanied by uncontrolled pulmonary cytokine release, sepsis and death, whereas wild-type mice clear the infection. Ksr1 recruits and assembles inducible nitric oxide (NO) synthase (iNOS) and heat shock protein-90 (Hsp90) to enhance iNOS activity and to release NO upon infection. Ksr1 deficiency prevents lung alveolar macrophages and neutrophils from activating iNOS, producing NO and killing bacteria. Restoring NO production restores the bactericidal capability of Ksr1-deficient lung alveolar macrophages and neutrophils and rescues Ksr1-deficient mice from P. aeruginosa infection. Our findings suggest that Ksr1 functions as a previously unknown scaffold that enhances iNOS activity and is therefore crucial for the pulmonary response to P. aeruginosa infections.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , & Pseudomonas aeruginosa: role in the pathogenesis of the CF lung lesion. Semin. Respir. Crit. Care Med. 24, 671–680 (2003).

  2. 2.

    & New insights into pulmonary inflammation in cystic fibrosis. Arch. Dis. Child. 91, 786–788 (2006).

  3. 3.

    & What are the important risk factors for healthcare-associated pneumonia? Semin. Respir. Crit. Care Med. 30, 26–35 (2009).

  4. 4.

    American Thoracic Society & Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 171, 388–416 (2005).

  5. 5.

    Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 15, 138–142 (2009).

  6. 6.

    & Inflammatory bowel disease reveals the kinase activity of KSR1. J. Clin. Invest. 114, 1233–1237 (2004).

  7. 7.

    et al. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 89, 63–72 (1997).

  8. 8.

    KSR: a MAPK scaffold of the Ras pathway? J. Cell Sci. 114, 1609–1612 (2001).

  9. 9.

    , , , & KSR is a scaffold required for activation of the ERK/MAPK module. Genes Dev. 16, 427–438 (2002).

  10. 10.

    et al. Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo. Mol. Cell. Biol. 22, 3035–3045 (2002).

  11. 11.

    et al. Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice. Cancer Res. 63, 4232–4238 (2003).

  12. 12.

    et al. Pharmacologic inactivation of kinase suppressor of ras-1 abrogates Ras-mediated pancreatic cancer. Nat. Med. 9, 1266–1268 (2003).

  13. 13.

    et al. CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat. Cell Biol. 8, 933–944 (2006).

  14. 14.

    , , , & Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia. Infect. Immun. 77, 5300–5310 (2009).

  15. 15.

    Recognition of bacterial endotoxin in the lungs. Am. J. Respir. Cell Mol. Biol. 23, 128–132 (2000).

  16. 16.

    , , & Acid sphingomyelinase amplifies redox signaling in Pseudomonas aeruginosa–induced macrophage apoptosis. J. Immunol. 181, 4247–4254 (2008).

  17. 17.

    , & Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12, 64–76 (2000).

  18. 18.

    et al. Dexamethasone impairs pulmonary defence against Pseudomonas aeruginosa through suppressing iNOS gene expression and peroxynitrite production in mice. Clin. Exp. Immunol. 126, 266–273 (2001).

  19. 19.

    , & Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis. Infect. Immun. 68, 2142–2147 (2000).

  20. 20.

    et al. Kinase suppressor of Ras forms a multiprotein signaling complex and modulates MEK localization. Mol. Cell. Biol. 19, 5523–5534 (1999).

  21. 21.

    & Kinase suppressor of ras is necessary for tumor necrosis factor alpha activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells. Cancer Res. 61, 963–969 (2001).

  22. 22.

    & Heat shock protein 90 as an endogenous protein enhancer of inducible nitric-oxide synthase. J. Biol. Chem. 278, 36953–36958 (2003).

  23. 23.

    , , & Specific association of nitric oxide synthase-2 with Rac isoforms in activated murine macrophages. Am. J. Physiol. Renal Physiol. 281, F326–F336 (2001).

  24. 24.

    et al. Up-regulation of Fas expression by Pseudomonas aeruginosa–infected endothelial cells depends on modulation of iNOS and enhanced production of NO induced by bacterial type III secreted proteins. Int. J. Mol. Med. 18, 355–363 (2006).

  25. 25.

    , , , & Up-regulation of Fas (CD95) expression in tumour cells in vivo. Immunology 120, 502–511 (2007).

  26. 26.

    et al. CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa. Science 290, 527–530 (2000).

  27. 27.

    , & Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J. Exp. Med. 195, 1155–1166 (2002).

  28. 28.

    , , , & Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J. Exp. Med. 192, 227–236 (2000).

  29. 29.

    & Nitric oxide synthases: roles, tolls and controls. Cell 78, 915–918 (1994).

  30. 30.

    et al. Kinase suppressor of Ras-1 protects intestinal epithelium from cytokine-mediated apoptosis during inflammation. J. Clin. Invest. 114, 1272–1280 (2004).

  31. 31.

    et al. The MAPK scaffold kinase suppressor of Ras is involved in ERK activation by stress and proinflammatory cytokines and induction of arthritis. J. Immunol. 177, 6152–6158 (2006).

Download references

Acknowledgements

We thank R. Kolesnick (Memorial Sloan-Kettering Cancer Center) for providing us with Ksr1-deficient mice. This study was supported by Deutsche Forschungsgemeinschaft grants Gu 335/13-3 and Gu 335/16-2 to E.G.

Author information

Author notes

    • Yang Zhang
    •  & Xiang Li

    These authors contributed equally to this work.

Affiliations

  1. Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany.

    • Yang Zhang
    • , Xiang Li
    • , Alexander Carpinteiro
    • , Matthias Soddemann
    •  & Erich Gulbins
  2. Department of Cell and Developmental Biology, Vanderbilt University School of Medicine and Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, USA.

    • Jeremy A Goettel

Authors

  1. Search for Yang Zhang in:

  2. Search for Xiang Li in:

  3. Search for Alexander Carpinteiro in:

  4. Search for Jeremy A Goettel in:

  5. Search for Matthias Soddemann in:

  6. Search for Erich Gulbins in:

Contributions

Y.Z. performed the internalization assays, confocal and fluorescence microscopy, immunoprecipitation studies, flow cytometry analysis and protein overexpression and iNOS activity assays. X.L. conducted the mouse infection experiments, determined cytokine abundance in the lung and performed the bacterial-killing assay and immunoblot analysis. A.C. performed bone marrow transplantation and determined the neutrophil count. M.S. characterized the genotypes of Ksr1-deficient mice. J.A.G. cloned recombinant Ksr proteins. Y.Z., X.L. and E.G. designed the experiments and wrote the manuscript.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Erich Gulbins.

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Notes 1–3, Supplementary Figures 1–6 and Supplementary Methods

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nm.2296

Further reading